直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
    • AI + Finnegan
    • Appeals, Issues, and Legal Strategy
    • Diligence, Licensing, and Opinions
    • Global IP Enforcement, Litigation, and Trials
    • Patent Office Invalidation Proceedings
    • Prosecution and Portfolio Management
    • Trademark and Brand Management
    • AI, Electronics, and Information Technology
    • Chemicals, Industrials, and Materials
    • Communications
    • Consumer Goods and Services
    • Energy
    • Hospitality, Gaming, and Leisure
    • Life Sciences
    • Transportation and Logistics
  • Experience

Experience

Alzheimer's Institute of America, Inc. v. Eli Lilly and Company

Alzheimer's Institute of America, Inc.

Eli Lilly and Company

Represented Eli Lilly in suit concerning technology used in searching for drugs to treat Alzheimer's disease. Obtained dismissal with prejudice based on lack of standing; also obtained a finding of exceptional case, entitling client to an award of attorneys' fees.

Alzheimer's Institute of America, Inc. v. Eli Lilly and Company, 3:10-cv-00482, N.D. Cal., Judges Breyer, James, Laporte

Related Practices

Global IP Enforcement, Litigation, and Trials

Pretrial Strategies

Related Industries

Life Sciences

Pharmaceutical

Biotechnology

Related Experiences

Hospira, Inc. v. Eli Lilly and Co.

Eli Lilly and Co.

Eli Lilly and Company v. Genentech, Inc.

Eli Lilly and Company

Chiron Corp. v. Eli Lilly and Vertex Pharmaceutical

Eli Lilly and Vertex Pharmaceuticals 

Eli Lilly and Company v. Teva Pharmaceuticals USA, Inc.

Eli Lilly and Company

Alzheimer's Institute of America, Inc. v. Avid Radiopharmaceuticals

Avid Radiopharmaceuticals

Eli Lilly and Company v. Actavis Labs. UT Inc.

Eli Lilly and Company

Synthon Pharmaceuticals, Inc. v. Eli Lilly and Co.

Eli Lilly and Co.; ICOS

Eli Lilly and Co. v. Apotex Inc.

Eli Lilly and Company

With hundreds of millions of dollars at stake in revolutionary technology involving genetic engineering, Finnegan prevails for Eli Lilly

Eli Lilly

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP